Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Dihydrolipoyl succinyl transferase (DLST), the E2 component ...

Class:IdSummation:9853764
_displayNameDihydrolipoyl succinyl transferase (DLST), the E2 component ...
_timestamp2023-11-21 10:21:23
created[InstanceEdit:9853770] Stephan, Ralf, 2023-11-21
textDihydrolipoyl succinyl transferase (DLST), the E2 component of the 2-oxoglutarate dehydrogenase metabolon, self-associates into a cubic octamer of homotrimers. The trimer appears to be the minimal conformation for optimal activity. It transfers the succinyl moiety bound to one of its N6-dihydrolipoyllysine residues onto the substrate CoA (Nakano et al., 1994; Nagy et al., 2021). Mutations in DLST can lead to benign pheochromocytomas and paragangliomas (PGL7; MIM:618475; Remacha et al., 2019).
(summation)[Reaction:9853512] DLST transfers succinyl to CoA [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Dihydrolipoyl succinyl transferase (DLST), the E2 component ... (9853764)